Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ruth Bruno"'
Autor:
Afiqah Yusuf, Iskra Peltekova, Tal Savion-Lemieux, Jennifer Frei, Ruth Bruno, Ridha Joober, Jennifer Howe, Stephen W Scherer, Mayada Elsabbagh
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0223119 (2019)
Understanding the overall utility of biological testing for autism spectrum disorder (ASD) is essential for the development and integration of biomarkers into routine care. One measure related to the overall utility of biological testing is the knowl
Externí odkaz:
https://doaj.org/article/28f5d12bf703480ead12892384f291ad
Autor:
Tracy Vaillancourt, Mandy Steiman, Eric Fombonne, Susan E. Bryson, Pat Mirenda, Mayada Elsabbagh, Eric Duku, Joanne Volden, Lonnie Zwaigenbaum, Rebecca Simon, Isabel M. Smith, Charlotte Waddell, Wendy Roberts, Peter Szatmari, Ruth Bruno, Stelios Georgiades, Teresa Bennett
Publikováno v:
Paediatrics & Child Health. 24:e57-e65
BACKGROUND: Early diagnosis of autism spectrum disorder (ASD) is essential in most Canadian jurisdictions to access interventions that improve long-term child outcomes. Our main objective was to identify factors associated with timing of ASD diagnosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7d83fa9b0ea344451c4793b43b0fde
https://doi.org/10.1093/pch/pxy076
https://doi.org/10.1093/pch/pxy076
Autor:
Jennifer L. Howe, Ruth Bruno, Mayada Elsabbagh, Tal Savion-Lemieux, Ridha Joober, Afiqah Yusuf, Jennifer Frei, Iskra Peltekova, Stephen W. Scherer
Publikováno v:
Research in developmental disabilities. 100
Background The clinical integration of chromosomal microarray testing promises improvements in diagnostic yields in Autism Spectrum Disorder (ASD). While the impact on clinical management is promising for some families, the utility perceived by famil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a788da52ecfe7f63fc5fd5403a52d8a2
https://pubmed.ncbi.nlm.nih.gov/32120048
https://pubmed.ncbi.nlm.nih.gov/32120048
Autor:
Ridha Joober, Ruth Bruno, Afiqah Yusuf, Jennifer L. Howe, Stephen W. Scherer, Jennifer Frei, Mayada Elsabbagh, Iskra Peltekova, Tal Savion-Lemieux
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 9, p e0223119 (2019)
PLoS ONE, Vol 14, Iss 9, p e0223119 (2019)
Understanding the overall utility of biological testing for autism spectrum disorder (ASD) is essential for the development and integration of biomarkers into routine care. One measure related to the overall utility of biological testing is the knowl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a885a191c69d5e2d478379a01fb0ada
http://europepmc.org/articles/PMC6763195
http://europepmc.org/articles/PMC6763195
Publikováno v:
Autism Research. 5:180-189
In order to conduct the screening phase of the first epidemiological survey of autism spectrum disorders (ASDs) in Mexico, we needed a screening tool to detect autistic symptomatology in a large sample of school-age children. We used the Spanish vers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dc5fad5772e52f3f259cdeca89020c0
https://doi.org/10.1002/aur.1235
https://doi.org/10.1002/aur.1235
Autor:
Carlos Marcin, Michele E. Villalobos, Ruth Bruno, Katrina Ramsay, Benjamin E. Nealy, Eric Fombonne, Christian Diaz, Ana Cecilia Manero
Publikováno v:
Journal of autism and developmental disorders. 46(5)
There are no epidemiological data on autism for Mexico. This study was conducted to generate a first estimate of ASD prevalence in Mexico. We surveyed children age eight in Leon (Guanajuato). The sample was stratified in two strata: (1) children havi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::639f19781af9f9fd0cc8ab76c8826ead
https://pubmed.ncbi.nlm.nih.gov/26797939
https://pubmed.ncbi.nlm.nih.gov/26797939